• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖活体肾捐献者候选人的捐赠审批:代谢综合征的影响。

Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.

机构信息

Department of Surgery, Division of Transplantation, University of Alabama at Birmingham, AL.

Department of Medicine, Division of Transplant Nephrology, University of Alabama at Birmingham, AL.

出版信息

Surgery. 2019 Nov;166(5):940-946. doi: 10.1016/j.surg.2019.07.008. Epub 2019 Aug 20.

DOI:10.1016/j.surg.2019.07.008
PMID:31444005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6802288/
Abstract

BACKGROUND

The scarcity of organs available for transplantation has increased attempts to augment transplantation by utilizing obese living kidney donors. The literature has suggested that these donors have increased risks postdonation. Not surprising, the threshold for living kidney donor approval among obese persons is typically higher and the process more costly. Therefore, a screening tool to predict the likelihood of approval among obese living kidney donor candidates was created.

METHODS

A single-center retrospective study was performed among obese (body mass index ≥ 30 kg/m2) living kidney donor candidates evaluated in clinic (January 1, 2012, to December 31, 2017). Approved candidates were compared with those not approved using multivariable logistic regression, and a prediction tool was generated.

RESULTS

Among 389 obese living kidney donor candidates, there were no significant differences in sex or race and ethnicity by approval status. However, nonapproved candidates had a higher prevalence of metabolic syndrome. In the prediction model, glucose impairment and hypertension were most predictive of nonapproval.

CONCLUSION

Among obese living kidney donor candidates, several metabolic syndrome components were associated with decreased odds of approval. This tool may serve as a useful initial screening for obese living kidney donor candidates, permitting more cost-effective evaluation processes. The tool could also be used to promote expeditious interventions in the preclinical setting, including weight management programs, to improve the likelihood of donation and postdonation outcomes.

摘要

背景

可供移植的器官稀缺,促使人们增加利用肥胖活体肾脏捐献者来增加移植数量的尝试。文献表明,这些捐献者在捐赠后存在更高的风险。毫不奇怪,肥胖者成为活体肾脏捐献者的门槛通常更高,且过程更昂贵。因此,创建了一种预测肥胖活体肾脏捐献者候选者获得批准可能性的筛选工具。

方法

对 2012 年 1 月 1 日至 2017 年 12 月 31 日在诊所评估的肥胖(体重指数≥30kg/m2)活体肾脏捐献者候选者进行了单中心回顾性研究。使用多变量逻辑回归比较获得批准和未获得批准的候选者,并生成预测工具。

结果

在 389 名肥胖活体肾脏捐献者候选者中,按批准状态,在性别或种族和民族方面没有显著差异。然而,未获批准的候选者代谢综合征的患病率更高。在预测模型中,葡萄糖受损和高血压对未获批准的预测最具预测性。

结论

在肥胖活体肾脏捐献者候选者中,几种代谢综合征成分与批准几率降低有关。该工具可用作肥胖活体肾脏捐献者候选者的有用初始筛选,从而实现更具成本效益的评估过程。该工具还可用于促进临床前环境中的快速干预,包括体重管理计划,以提高捐赠和捐赠后结果的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/6273530648e5/nihms-1535063-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/392352f16549/nihms-1535063-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/38fa094dc3e9/nihms-1535063-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/6273530648e5/nihms-1535063-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/392352f16549/nihms-1535063-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/38fa094dc3e9/nihms-1535063-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f3/6802288/6273530648e5/nihms-1535063-f0003.jpg

相似文献

1
Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.肥胖活体肾捐献者候选人的捐赠审批:代谢综合征的影响。
Surgery. 2019 Nov;166(5):940-946. doi: 10.1016/j.surg.2019.07.008. Epub 2019 Aug 20.
2
Impact of screening for metabolic syndrome on the evaluation of obese living kidney donors.
Am J Surg. 2018 Jan;215(1):144-150. doi: 10.1016/j.amjsurg.2017.08.019. Epub 2017 Sep 1.
3
Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.超重对肾脏捐献的影响:肥胖供体肾切除术的长期后果。
Surgery. 2018 Nov;164(5):1071-1076. doi: 10.1016/j.surg.2018.07.015. Epub 2018 Aug 24.
4
Patient Perspectives on Weight Management for Living Kidney Donation.患者对活体肾脏捐献者体重管理的看法。
J Surg Res. 2019 Dec;244:50-56. doi: 10.1016/j.jss.2019.06.026. Epub 2019 Jul 3.
5
Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors.肥胖活体肾捐献者 6 个月捐后随访失败的中心变异性和危险因素。
Transplantation. 2019 Jul;103(7):1450-1456. doi: 10.1097/TP.0000000000002508.
6
Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.肥胖供肾者的中期肾脏结局、肾衰竭和死亡率。
J Am Soc Nephrol. 2021 Nov;32(11):2933-2947. doi: 10.1681/ASN.2021040548. Epub 2021 Oct 21.
7
Obesity and long-term mortality risk among living kidney donors.肥胖与活体肾脏捐献者的长期死亡风险。
Surgery. 2019 Aug;166(2):205-208. doi: 10.1016/j.surg.2019.03.016. Epub 2019 May 7.
8
GFR Assessment of Living Kidney Donors Candidates.活体肾捐献者候选人的肾小球滤过率评估。
Transplantation. 2019 Jun;103(6):1086-1093. doi: 10.1097/TP.0000000000002620.
9
Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors.时间趋势、中心水平差异,以及流行州肥胖率对肥胖活体肾脏供者接受度的影响。
Am J Transplant. 2018 Mar;18(3):642-649. doi: 10.1111/ajt.14519. Epub 2017 Oct 30.
10
Hand-Assisted Nephrectomy Predisposes Incisional Herniation in Obese Living Donors.手辅助肾切除术易导致肥胖活体供者发生切口疝。
Transplant Proc. 2019 Sep;51(7):2210-2214. doi: 10.1016/j.transproceed.2019.02.042. Epub 2019 Aug 1.

引用本文的文献

1
Concerns and Challenges of Living Donors When Making Decisions on Organ Donation: A Qualitative Study.活体捐赠者在做出器官捐赠决策时的担忧与挑战:一项定性研究
Iran J Nurs Midwifery Res. 2022 Mar 14;27(2):149-156. doi: 10.4103/ijnmr.ijnmr_158_21. eCollection 2022 Mar-Apr.
2
Donor-reported barriers to living kidney donor follow-up.供者报告的活体肾移植受者随访障碍。
Clin Transplant. 2022 May;36(5):e14621. doi: 10.1111/ctr.14621. Epub 2022 Feb 27.
3
Hypertension and obesity in living kidney donors.活体肾供体中的高血压与肥胖

本文引用的文献

1
Impact of screening for metabolic syndrome on the evaluation of obese living kidney donors.
Am J Surg. 2018 Jan;215(1):144-150. doi: 10.1016/j.amjsurg.2017.08.019. Epub 2017 Sep 1.
2
A multicenter cohort study of potential living kidney donors provides predictors of living kidney donation and non-donation.一项多中心队列研究潜在活体供肾者,提供了活体肾捐赠和不捐赠的预测因素。
Kidney Int. 2017 Nov;92(5):1249-1260. doi: 10.1016/j.kint.2017.04.020. Epub 2017 Jul 12.
3
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.载脂蛋白 L1 与年轻潜在活体供肾者的慢性肾脏病风险。
World J Transplant. 2021 Jun 18;11(6):180-186. doi: 10.5500/wjt.v11.i6.180.
Ann Surg. 2018 Jun;267(6):1161-1168. doi: 10.1097/SLA.0000000000002174.
4
Obesity increases the risk of end-stage renal disease among living kidney donors.肥胖会增加活体肾供者发生终末期肾病的风险。
Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.
5
Facing the Metabolic Syndrome Epidemic in Living Kidney Donor Programs.直面活体肾供体项目中的代谢综合征流行问题。
Ann Transplant. 2016 Jul 22;21:456-62. doi: 10.12659/aot.898560.
6
The Medically Complex Living Kidney Donor: Glucose Metabolism as Principal Cause of Donor Declination.
Ann Transplant. 2016 Jan 26;21:39-45. doi: 10.12659/aot.895729.
7
Perioperative Complications After Living Kidney Donation: A National Study.活体肾捐献后的围手术期并发症:一项全国性研究。
Am J Transplant. 2016 Jun;16(6):1848-57. doi: 10.1111/ajt.13687. Epub 2016 Mar 10.
8
Weight trends in United States living kidney donors: Analysis of the UNOS database.美国活体肾供体的体重趋势:器官共享联合网络数据库分析
World J Transplant. 2015 Sep 24;5(3):137-44. doi: 10.5500/wjt.v5.i3.137.
9
Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study.肾脏捐赠成人的预捐赠直接和间接成本:KDOC研究的结果
Am J Transplant. 2015 Sep;15(9):2387-93. doi: 10.1111/ajt.13286. Epub 2015 May 5.
10
Impact of metabolic syndrome on postdonation renal function in living kidney donors.代谢综合征对活体肾供者捐献后肾功能的影响。
Transplant Proc. 2015 Mar;47(2):290-4. doi: 10.1016/j.transproceed.2014.10.051.